Show simple item record

dc.contributor.authorTan, L
dc.contributor.authorSandhu, S
dc.contributor.authorLee, R
dc.contributor.authorLi, J
dc.contributor.authorCallahan, J
dc.contributor.authorRaleigh, J
dc.contributor.authorHatzimihalis, A
dc.contributor.authorMiddlehurst, P
dc.contributor.authorHenderson, M
dc.contributor.authorShackleton, M
dc.contributor.authorHaydon, A
dc.contributor.authorGyorki, D
dc.contributor.authorOudit, Deemesh
dc.contributor.authorHicks, R
dc.contributor.authorLorigan, Paul C
dc.contributor.authorMcArthur, G
dc.contributor.authorMarais, Richard
dc.contributor.authorWong, S
dc.contributor.authorDawson, S
dc.date.accessioned2019-04-29T09:48:56Z
dc.date.available2019-04-29T09:48:56Z
dc.date.issued2018en
dc.identifier.citationTan L, Sandhu SK, Lee R, Li J, Callahan J, Raleigh J, et al. 52OCirculating tumour DNA analysis predicts relapse following resection in stage II and III melanoma. Ann Oncol. 2018;29(suppl_8).en
dc.identifier.doi10.1093/annonc/mdy269.050en
dc.identifier.urihttp://hdl.handle.net/10541/621759
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdy269.050en
dc.titleCirculating tumour DNA analysis predicts relapse following resection in stage II and III melanomaen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMedical Oncology, Peter MacCallum Cancer Center, Melbourne, Australiaen
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record